EXHIBIT 10.12 AMENDED AND RESTATED EXCLUSIVE SUBLICENSE AGREEMENT BY AND BETWEEN INTERMUNE PHARMACEUTICALS, INC.License Agreement • March 22nd, 2000 • Intermune Pharmaceuticals Inc • Pharmaceutical preparations • California
6,325,000 Shares Common Stock ($0.001 Par Value)Underwriting Agreement • March 22nd, 2000 • Intermune Pharmaceuticals Inc • Pharmaceutical preparations • New York
INTERMUNE PHARMACEUTICALS, INC. ---------------------------- COLLABORATION AGREEMENTCollaboration Agreement • March 22nd, 2000 • Intermune Pharmaceuticals Inc • Pharmaceutical preparations • California
BACKGROUNDTransition Agreement • March 22nd, 2000 • Intermune Pharmaceuticals Inc • Pharmaceutical preparations • California
SUPPLY AGREEMENT This Supply Agreement ("Agreement") is entered into as of May 5, 1998 (the "Effective Date") between Genentech, Inc., a Delaware corporation, with its principal offices at 1 DNA Way, South San Francisco, California 94080 ("Genentech")...Supply Agreement • March 22nd, 2000 • Intermune Pharmaceuticals Inc • Pharmaceutical preparations • California
